https://www.selleckchem.com/pr....oducts/pyridostatin-
The Rotterdam Prostate Cancer Risk calculator (RPCRC) has been validated in the past years. Recently a new version including multiparametric magnetic resonance imaging (mpMRI) data has been released. The aim of our study was to analyze the performance of the mpMRI RPCRC app. A series of men undergoing prostate biopsies were enrolled in eleven Italian centers. Indications for prostate biopsy included abnormal Prostate specific antigen levels (PSA4ng/ml), abnormal DRE and abnormal mpMRI. Patients' characteri
Like
Comment
Share
